{
    "clinical_study": {
        "@rank": "85552", 
        "arm_group": {
            "arm_group_label": "Grape", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The objectives of this study are the following: 1) to confirm that the administration of\n      grape juice, resveratrol, and grape seed polyphenol extract results in a similar plasma and\n      urinary metabolic profile in aged humans compared to rats, 2) to confirm that a combined\n      administration of grape juice, resveratrol, and grape seed polyphenol extract result in a\n      similar plasma and urinary metabolic profile in adults with tendencies toward metabolic\n      syndrome compared to non-obese healthy humans, and 3) to identify the anti-inflammatory\n      effects of the combined administration of grape juice, resveratrol, and grape seed\n      polyphenol extract."
        }, 
        "brief_title": "Grape Polyphenol Kinetics in Humans", 
        "completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "condition": "The Focus of the Study is to Investigate the Plasma and Urinary Metabolic Profile of Grape Juice, Resveratrol, and Grape Seed Polyphenol Extract.", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -\n\n        Exclusion Criteria:\n\n          -  Age <60 years at beginning of study\n\n          -  Fasting glucose > 126 mg/dl\n\n          -  Blood pressure > 160/100\n\n          -  Fasting total blood cholesterol > 280 mg/dl\n\n          -  Fasting triglycerides > 300 mg/dl\n\n          -  Presence of kidney disease, liver disease, gout, hyperthyroidism, untreated or\n             unstable hypothyroidism, certain cancers, gastrointestinal disease, pancreatic\n             disease, other metabolic diseases, or malabsorption syndromes\n\n          -  Presence of type 2 diabetes requiring the use of oral antidiabetic agents or insulin\n\n          -  History of bariatric or certain other surgeries related to weight control\n\n          -  Smokers or other tobacco users (during 6 months prior to the start of the study)\n\n          -  Consumption of more than 3 servings of tea, wine, or grape juice per day\n\n          -  Use of supplements containing grape extracts or products\n\n          -  Use of antibiotics during the intervention or for 3 weeks prior to the intervention\n             period\n\n          -  History of eating disorders, dietary patterns, or supplement use which will interfere\n             with the goal of the intervention\n\n          -  Volunteers who have lost 10% of body weight within the last 4 months\n\n          -  Volunteers who are unable or unwilling to give informed consent or communicate with\n             study staff\n\n          -  Volunteers who self-report of alcohol or substance abuse within the past 12 months\n             and/or current acute treatment or rehabilitation program for these problems\n             (long-term participation in Alcoholics Anonymous is not an exclusion)\n\n          -  Other medical, psychiatric, or behavioral factors that in the judgment of the\n             Principal Investigator may interfere with study participation or the ability to\n             follow the intervention protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "59 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01751750", 
            "org_study_id": "HS38"
        }, 
        "intervention": {
            "arm_group_label": "Grape", 
            "description": "16 oz. of Concord grape juice (8 oz. consumed 2 times per day; total dose of approximately 1.2 g phenolic compounds per day), 250 mg resveratrol provided as a capsule (commercially available supplement; 125 mg consumed 2 times per day), and 1 g grape seed polyphenol extract provided as a capsule (commercially available supplement; 0.5 g consumed 2 times per day).", 
            "intervention_name": "Grape", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 13, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Beltsville", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20705"
                }, 
                "name": "USDA Beltsville Human Nutrition Research Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "overall_official": {
            "affiliation": "USDA Beltsville Human Nutrition Research Center", 
            "last_name": "Janet Novotny, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Blood will be analyzed for polyphenols and polyphenol metabolites.", 
                "measure": "Plasma polyphenols", 
                "safety_issue": "No", 
                "time_frame": "6 hours"
            }, 
            {
                "description": "Urine will be analyzed for polyphenols and polyphenol metabolites.", 
                "measure": "Urinary polyphenols", 
                "safety_issue": "No", 
                "time_frame": "6 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01751750"
        }, 
        "responsible_party": {
            "investigator_affiliation": "USDA Beltsville Human Nutrition Research Center", 
            "investigator_full_name": "Janet Novotny", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "USDA Beltsville Human Nutrition Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Janet Novotny", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}